Tofacitinib for sarcoidosis, a new potential treatment

James Cheng-Chung Wei is Editor-in-Chief of the journal and co-author of this article. He was excluded from the peer-review process and all editorial decisions related to the acceptance and publication of this article. Peer-review was handled independently by Associate Editor Chih-Wei Chen to minimize bias.